Our Latest News

  • Cleveland Center for Membrane and Structural Biology Makes Breakthrough Neurological Discoveries

    Sudha Chakrapani and her team of researchers understand that exploring the smallest molecular structures requires advanced instrumentation, big data and state-of-the-art shared resources. Recently appointed Director of the Cleveland Center for Membrane and Structural Biology (CCMSB), Chakrapani’s team is discovering breakthroughs in the new Cryo-EM Core facility, home to the first cryo-electron microscope in the Greater Cleveland area.
  • Student Spotlight - Caroline Schuerger

    Blazing trails by blending hard science with public health and social policy

    Caroline Schuerger is serious about combining medical research and science advocacy to advance public health. After earning her undergraduate degree at University of North Carolina, Chapel Hill, she enrolled in the Cleveland Clinic Lerner College of Medicine (CCLCM), studying translational hematology and oncology research. 

  • UH and CWRU announce clinical trial of AstraZeneca's COVID-19 vaccine candidate

    University Hospitals (UH) and Case Western Reserve University (CWRU) announced recently that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca (LSE/STO/NYSE: AZN). The trial is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. UH is part of the NIAID-supported COVID-19 Prevention Network (CoVPN). UH will study AZD1222 as one of approximately 80 clinical investigational sites in the U.S. that will collectively enroll up to 30,000 participants.  
  • Using AI to improve heart-transplant outcomes

    Madabhushi lab working with researchers from Perelman School of Medicine at University of Pennsylvania, Cleveland Clinic and Cedars-Sinai Medical Center to begin training computers to glean from pathology images which patients will accept, reject heart transplant The team of biomedical researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) has tackled various aspects of lung cancer, breast cancer, colon cancer and more since the center was launched at Case Western Reserve University in 2012 by bioengineering pioneer Anant Madabhushi.
  • New research reveals why low oxygen damages the brain

    Researchers uncover surprising dark side to the body’s normally protective low oxygen response system Brain cell dysfunction in low oxygen is, surprisingly, caused by the very same responder system that is intended to be protective, according to a new published study by a team of researchers at Case Western Reserve University School of Medicine.
  • Stan Gerson to serve as School of Medicine interim dean for another year

    Interim President Scott Cowen and Provost Ben Vinson III announced today that Interim Dean Stan Gerson has agreed to extend his term for another year, to June 30, 2022.
  • Dynamic COVID-19 dashboard developed by School of Medicine team

    As COVID-19 continues to spread, concerns about where and when it is safe to leave home may cause fear, frustration and fatigue. Part of that frustration may come from not having a quick, reliable source for accurate, up-to-date information on virus outbreaks.
  • $5.5 million NIH grant supports new tests to diagnose dementias earlier and easier

    Researchers at Case Western Reserve University School of Medicine seek to optimize emerging methods of diagnosing two common neurodegenerative diseases—dementia with Lewy bodies and Parkinson’s disease dementia—which affect 1.4 million in the United States

    With a $5.5 million, five-year award from the National Institutes of Health (NIH), researchers at Case Western Reserve University will seek to systemize new diagnostic tests for dementia with Lewy bodies and Parkinson’s disease dementia—together the second-most-common dementias after Alzheimer’s disease.

  • Performing robotic medical procedures inside an MRI

    Case Western Reserve University scientists are working toward performing heart catheterization and cardiac ablation with a micro robotic device, controlled by a doctor wearing a mixed-reality headset—all while the patient is inside a magnetic resonance imaging (MRI) machine.
  • New study calculates lifetime risk of death from firearms and drug overdoses in the United States

    One of every 100 American children will die from firearms if current death rates continue; one of every 70 will die from overdoses

    A new study published in The American Journal of Medicine calculates the lifetime risk of death from firearms and drug overdoses in the United States.

  • Health Care Cleveland—COVID, 2020 and Beyond

    A Series of Health Care Forums Addressing Today’s Most Demanding Global Health Care Issues 

    The first presidential debate leading up to the election in November was held on September 29 at the Health Education Campus, where candidates addressed demanding health care issues in addition to other critical topics. Cleveland is the nation’s leader in health care research and delivery, innovation, biotechnology, medical and interprofessional education, and health care reform.

  • Congratulations to the Physician Assistant Class of 2020!

    We salute 34 students who graduated from the School of Medicine's physician assistant (PA) Class of 2020 on Sunday, August 30. Like many other firsts we’ve experienced this year, this was the first PA class to graduate virtually.  
  • New study finds hydroxychloroquine ineffective as preventive antiviral against COVID-19

    Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population.
  • Scientists work to freeze-dry synthetic platelets

    A Case Western Reserve University scientist, who has for more than a decade pioneered research into synthetic platelet substitutes, has been awarded a $3.8 million grant by the U.S. Department of Defense (DOD) to develop freeze-dried artificial platelets that can treat bleeding in wounded soldiers in the battlefield before they can be taken to a hospital.
  • A measured approach

    ​Physicians and nurses rush into a hospital room when a patient is in crisis or near death. It’s both instinctive and engrained by practice. But amid the pandemic, there’s no dashing in. Instead there’s a methodical donning of personal protective equipment (PPE) to avoid contamination and further spread of the coronavirus—“and then you go into a room,” said Edward Warren, MD (MED ’87), division director of pulmonary/critical care and sleep medicine at The MetroHealth System in Cleveland and an associate professor of medicine at Case Western Reserve. ​